In November, Gibson received a diagnosis of Fowler’s syndrome — a rare, often underdiagnosed condition that causes the ...
Since February 2024, Caris Gibson, from Oxfordshire, has been battling severe symptoms of Fowler’s Syndrome – a rare, chronic condition that predominantly affects women in their 20s and 30s, ...
A 21-year-old woman who suffers from a rare urinary retention condition that causes debilitating pain and repeated infections ...
A 21-year-old woman who suffers from a rare urinary retention condition that causes debilitating pain and repeated infections ...
One of the more common complications is a ureteral obstruction, which is a blockage of the tubes that drain from the kidneys into the bladder. “The tumor can block the ability of urine to flow from ...
The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the treatment of bladder cancer. The PD-1/antibody-drug conjugate pairing ...
Botox can cause temporary redness, swelling, tenderness, or bruising at the injection site. You may get flu-like symptoms like fever, body aches, or nausea after Botox. Botox may cause headaches, ...
“I know from my own experience that a cancer diagnosis can feel overwhelming,” the King said in a televised address from the Morning Room at Clarence House. “Yet I also know that early detection is ...
Adenocarcinoma of the bladder is rare, originating from glandular cells, and can be primary or secondary, requiring accurate diagnosis for appropriate treatment. Diagnosis involves cystoscopy, biopsy, ...
TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...
The FDA has approved Pfizer and Astellas’ Padcev (enfortumab vedotin-ejfv) plus Merck’s Keytruda (pembrolizumab) as a perioperative treatment for adults with muscle-invasive bladder cancer who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results